This study aimed to evaluate the expression of CB1R and CB2R in plasma-derived exosomes of patients with NAFLD and to investigate the in vitro effects of circulating exosomes in cultured human HepaRG cells. This evidence concerns the gene CNR1 and metabolic dysfunction-associated steatotic liver disease.